Previous Article | Next Article 
J Bacteriol, June 1998, p. 3026-3030, Vol. 180, No. 12
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
In Vivo Analysis of Sequence Requirements for
Processing and Degradation of the Colicin A Lysis Protein Signal
Peptide
S. Peter
Howard* and
Lisa
Lindsay
University of Regina, Regina, Saskatchewan,
Canada S4S 0A2
Received 10 December 1997/Accepted 17 April 1998
 |
ABSTRACT |
The lipid modification and processing of a number of colicin lysis
proteins take place exceedingly slowly and result in the release of a
stable signal peptide. It is possible that this peptide or the presence
of lipid-modified precursors which result from the slow processing
plays a role in the release of colicins and in the quasilysis that
occurs in induced colicinogenic cultures. We used in vitro mutagenesis
and pulse-chase radiolabeling and immunoprecipitation to examine the
reasons for the slow processing and signal peptide degradation
reactions for the colicin A lysis protein (Cal). In one mutant,
isoleucine 13 was replaced with serine, and in another, alanine 18, the
last residue of the signal peptide, was replaced with glycine. In each
case, the mutation caused a striking increase in the rate of maturation
of the precursor, and in the case of the serine 13 derivative, the
mutation also destabilized the signal peptide. A precursor containing
both of these mutations was completely matured and its signal sequence degraded within seconds of its synthesis. The release of colicin A and
the quasilysis of producing cultures were unchanged for each of these
mutants, indicating that neither the stable signal peptide nor
lipid-modified processing intermediates of Cal are required for either
of these events in wild-type cells.
 |
INTRODUCTION |
Bacterial lipoproteins contain a
lipid-modified Cys as the first amino acid of the mature protein and
are synthesized as precursors with a consensus of
Leu-Ala/Ser-Gly/Ala-Cys at the cleavage site (11). The
sequence specificity for prolipoprotein modification and signal peptide
cleavage by signal peptidase II has been investigated in detail
elsewhere (10, 16, 27, 37). These studies have demonstrated
a requirement for the consensus cleavage site and in addition have
shown that the termination of the central hydrophobic region of the
signal sequence is important for efficient processing.
The signal sequence itself is rapidly degraded, and as a result, few
studies of sequence specificity for this degradation have been done,
although a number of proteases of Escherichia coli which are
capable of signal peptide hydrolysis have been identified (15, 25,
26). An exception to this rapid degradation exists in the colicin
lysis proteins (or bacteriocin release proteins), which are required
for the release of colicins from E. coli cells (8). A number of these small membrane lipoproteins are
processed unusually slowly, releasing stable signal peptides that
accumulate in the cytoplasmic membrane (4, 13, 22).
Experiments in which all but the last residue of the signal sequence of
the cloacin DF13 lysis protein were replaced by that of the major
lipoprotein of E. coli (or Braun's lipoprotein) showed that
these properties are due to the signal peptide itself rather than the
mature portion of the protein (23). A number of studies have
also examined the possible role of the stable signal peptide itself in
colicin release and in the partial lysis and cell death (quasilysis)
which occur as the colicin is released from induced cultures. In
studies of the processing and degradation of the cloacin DF13 lysis
protein signal peptide, a lysis protein synthesized with the unstable signal peptide of Braun's lipoprotein did not function in cloacin release but did cause lethality and quasilysis (23).
Expression of the stable signal peptide alone caused lethality and
quasilysis but no cloacin release, as did a number of hybrid lysis
protein-major lipoprotein signal peptides of varying stability
(33, 35). In addition, when the stable signal peptide and
the inactive lysis protein synthesized with an unstable signal peptide
were expressed together, a small amount of cloacin DF13 was released
from the cells (34). Kanoh et al. constructed a mutant
colicin E2 lysis protein which was composed of essentially only the
signal peptide and showed that this provoked cell death but was
inactive in colicin release (20). These results have
suggested that the lysis protein signal peptides may play a mechanistic
role in quasilysis and the release of colicins from producing cells,
perhaps through formation of a pore composed of the peptides and the
mature lysis protein (23, 33, 35).
In the studies described here, we have mutated specific amino acids of
the colicin A lysis protein (Cal) signal sequence, which resulted in
much faster processing, or both faster processing and destabilization
of the signal peptide, depending on the mutation. These results
indicated that the Ile residue at position 13 of this signal peptide is
chiefly responsible for its stability, while Ile13 and Ala18 both
contribute to the slow modification and processing of the precursor.
Colicin secretion studies with these mutants also demonstrated that
neither the accumulation of processing intermediates nor the
accumulation of stable signal peptides is required for either colicin
release or the quasilysis and cell death caused by this lysis protein.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and media.
E. coli W3110
and W3110 degP were used as the hosts for the induction
experiments, while HB101 was used as the host for all recombinant
constructions. Cultures used for [35S]methionine labeling
experiments were grown at 37°C in M9 medium supplemented with 0.5%
methionine assay medium, 4 mg of glycerol per ml, 10 µg of thiamine
per ml, and 50 µg of ampicillin per ml, while those labeled with
[3H]glycerol were grown in the same medium supplemented
with 4 mg of sodium lactate per ml rather than glycerol as the carbon
source. For quasilysis and colicin secretion assays, cultures were
grown in Luria-Bertani medium (24). The source of the
cal gene for the in vitro mutagenesis experiments was the
colicin A plasmid pKA, a derivative of pBR322 containing the entire
colicin A operon under the control of its natural SOS promoter
(12, 21).
Construction of cal mutations.
PCR was used as
previously described (32) to create the Ala18
Gly18 and
Ile13
Ser13 mutations in the cal gene of plasmid pKA. The
derivative pKAN was first constructed by using oligonucleotides PH4
(5' CAATTTTACGTAAAAGTAAAG) and PH3 (5'
GACTTGGCATGHCGGCTAGCAGCAT) to introduce a silent T
A mutation
at codon 16 of the cal gene, creating an NheI
site. This allowed oligonucleotides PH4 and PH7 (5'
TGCGGCTAGCAGCATGGACGCCAG) to be used to change the Ile13 codon (ATC) to Ser (TCC) in pKANS13 and oligonucleotides PH6 (5'
TGCTGCTAGCCGGATGCCAAG) and PH1 (5' CCTCTTGCGGGATATCGAGAG)
to be used to change the Ala18 codon (GCA) to the Gly codon (GGA)
in pKANG18. These mutations were then combined by exchanging an
NheI-HindIII fragment from pKANG18 containing
the Ala18
Gly18 mutation into pKANS13 to yield pKANS13G18. The
structure of each of the mutant cal genes was verified with
PH4 and PH1, which hybridize 5' and 3' to the cal gene,
respectively, as the sequencing primers (28). pBD2
derivatives of each of the plasmids containing the cal
mutations were constructed by digestion with SstI and
NcoI, treatment with the Klenow fragment of DNA polymerase
I, and reclosure of the plasmid as previously described (2).
Labeling and immunoprecipitation experiments.
W3110 cells
containing the various plasmids were induced with 300 ng of mitomycin C
per ml and labeled with [35S]methionine (>1,000 Ci/mmol)
after 45 min of induction as previously described (12),
except that the radioactive concentration was 1 mCi/ml. After various
periods of chase with 2.5 mg of unlabeled methionine per ml, 10-µl
samples were withdrawn from the cultures and mixed with an equal volume
of immunoprecipitation buffer containing 2% sodium dodecyl sulfate
(SDS), boiled to arrest further processing, and then diluted 30-fold
with immunoprecipitation buffer containing 1% Triton X-100, as
described by Ito et al. (19). The monoclonal antibody CA1,
coupled to Affi-Gel Hz (Bio-Rad), was added in excess (as determined in
preliminary experiments), and after overnight incubation at 4°C, the
immunoprecipitates were washed three times before being resuspended in
SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer and
electrophoresed (19). For lipoprotein labeling in the
presence or absence of globomycin, W3110 degP cells were
used as the host in order to reduce the degradation of
pCalm which occurs in the presence of this drug
(5). The cells were induced with 300 ng of mitomycin C per
ml, and when used, globomycin was added to a concentration of 100 µg/ml after a further 10 min. After an additional 10 min of
incubation, [2-3H]glycerol (200 µCi/ml, 11.5 Ci/mmol)
was used to pulse the cells for 30 min, after which they were
immunoprecipitated as described above.
Other methods.
SDS-PAGE was performed in a Tricine buffer
system (29). Gels containing the
[35S]methionine-labeled samples were dried and exposed
directly to X-ray film, while those which contained
[2-3H]glycerol-labeled proteins were first treated with
En3Hance (New England Nuclear) and then exposed to X-ray
film at
70°C. For immunoblots, proteins were transferred to
nitrocellulose paper as previously described (31), reacted
with CA1, and developed with alkaline phosphatase-conjugated goat
anti-mouse immunoglobulin G.
 |
RESULTS |
Lipid modification and processing of pCal.
Previous studies on
the processing and lipid modification of Cal have demonstrated that
these reactions take place very slowly compared to those of other
lipoproteins and that the signal peptide is stable after cleavage from
the precursor and accumulates in the inner membrane (3, 4,
13). Because it is difficult to unambiguously identify the
various assembly intermediates of Cal in whole-cell samples
(4), we used immunoprecipitation with the anti-Cal
monoclonal antibody CA1 (14) in conjunction with pulse-chase
analysis with [35S]methionine to study the processing and
lipid modification reactions. W3110(pKAN) cells were induced for the
production of colicin A and Cal with mitomycin C, pulsed for 1 min with
[35S]methionine, and chased for 30 min with unlabeled
methionine. Autoradiograms of SDS-PAGE gels of the samples showed the
immediate appearance of precursor Cal (pCal) and its conversion, with a half-life of approximately 10 min, to mature, lipid-modified Cal, while
lipid modified precursor Cal (pCalm) could not be
identified, since it comigrates with the major lipoprotein in this gel
system (Fig. 1). The bands corresponding to pCal, pCalm, and mature Cal could all be observed
throughout the chase period in the CA1 immunoprecipitates, indicating
that both the lipid modification of pCal and the cleavage of
pCalm are limiting reactions in the processing of this
precursor. To confirm the identities of the lipid-modified forms of
Cal, they were immunoprecipitated from
[3H]glycerol-labeled cells treated or not with
globomycin, an antibiotic which inhibits processing by signal peptidase
II and results in pCalm accumulation (5, 9, 18).
The autoradiogram of these immunoprecipitates indicated that only
pCalm and mature Cal were labeled by the
[3H]glycerol, and when the cells were treated with
globomycin, only the band corresponding to pCalm could be
immunoprecipitated (Fig. 2).

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 1.
Lipid modification and processing of pCal. W3110 cells
containing the colicin A plasmid pKAN were induced with mitomycin C or
not induced, pulsed for 1 min with [35S]methionine, and
chased with unlabeled methionine. After the periods of chase in minutes
indicated at the top of each lane, whole-cell samples or Cal
immunoprecipitates were separated by SDS-PAGE and visualized by
autoradiography. The positions of migration of pCal ( ),
pCalm ( ) (which comigrates with the major lipoprotein in
the whole-cell samples), Cal ( ), and the Cal signal peptide ( )
are indicated. Numbers at left indicate molecular mass in
kilodaltons.
|
|

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoprecipitation of pCalm and Cal after
[2-3H]glycerol labeling in the presence and absence of
globomycin. W3110 degP cells containing pKAN were left
uninduced (lanes 1, 2, 5, and 6) or induced with mitomycin C (lanes 3, 4, 7, and 8), and aliquots of each culture were treated with 50 µg of
globomycin per ml (lanes 1, 4, 5, and 8). The cells were then labeled
with [2-3H]glycerol and either directly electrophoresed
(lanes 1 to 4) or immunoprecipitated with CA1, with the
immunoprecipitates then being electrophoresed (lanes 5 to 8). The
positions of migration of pCalm ( ), Cal ( ), and
pLppm ( ) are indicated. Numbers at left indicate
molecular mass in kilodaltons.
|
|
The autoradiogram in Fig.
1 also shows the accumulation in the
whole-cell samples of a fourth band, with an apparent
Mr of
~2,000, during the lipid modification
and processing reactions.
The absence of this band during inhibition of
processing by either
globomycin (
5) or mutation
(
12) and the results of differential
labeling studies
(
6) have demonstrated that it is the stable
Cal signal
peptide which is cleaved from pCal
m by signal peptidase II
during the processing reaction.
In vitro mutagenesis of cal.
We used site-directed
mutagenesis, guided by previous studies of lipoprotein processing
(10, 11), to determine why the Cal signal sequence is so
slowly processed and degraded. Cal has the signal sequence Met Lys Lys
Ile Ile Ile Cys Val Ile Leu Leu Ala Ile Met Leu Leu Ala Ala. Although
the consensus lipoprotein cleavage sequence contains either Gly or Ala
in the
1 position (relative to the cleavage site), we created the
mutation Ala18
Gly18, because Gly is the most commonly occurring
1
residue in lipoproteins and because Ala has a much higher propensity
than Gly for
-helical conformation (7), whereas a
-turn structure in this region has been suggested to be important
for efficient processing of the major lipoprotein precursor
(16). The pCal signal sequence also differs from most others
in having no Ser or Thr residue at the end of the hydrophobic core, 5 to 7 residues amino-terminal to the cleavage site. The termination of a
core hydrophobic
-helix is also thought to be important to signal
sequence structure and function (37, 38), and we therefore
changed Ile13 to the more polar, turn-promoting Ser.
Processing and degradation of the Gly18 and Ser13 Cal signal
peptides.
The plasmids containing the cal mutations
were transformed into W3110 cells and pulse-chased and
immunoprecipitated as before. For each of the mutations, dramatic
increases in the rate of pCal processing were observed, as shown in
Fig. 3. The maturation of the Gly18
precursor was such that the majority of the labeled pCal had been
processed within 1 min of the end of the pulse, while most of the
labeled Ser13 derivative had been processed after 5 min. For both of
the mutants, the increased processing rate was such that it obscured
the precursor-product relationship between pCal and mature Cal that is
evident during the processing of the wild-type protein (Fig. 1). The
Ser13 mutation also had a dramatic effect on the degradation of the
signal peptide itself (Fig. 3). In contrast to both wild type and the
Gly18 mutant, the hydrolysis of the signal peptide of this mutant
closely followed the maturation of the precursor. In some gels,
including that shown in Fig. 3, this degradation appeared to proceed
via a cleavage which gave rise to a subfragment slightly lower in
molecular weight than the intact signal peptide, but this subfragment
could not always be reliably observed.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
Processing and degradation of Gly18 and Ser13 Cal signal
peptides. W3110 cells containing pKANG18 and pKANS13 were induced with
mitomycin C and pulse-labeled for 1 min with
[35S]methionine. Samples and immunoprecipitates of
samples taken after the chase times indicated in minutes were
electrophoresed, and autoradiographs were prepared. Symbols: , pCal;
, pCalm; , Cal; , Cal signal peptide.
|
|
Processing of the Ser13Gly18 double mutant.
Since both the
Ser13 and Gly18 mutations had a strong positive effect on the
processing of pCal, a plasmid which encoded a pCal which contained both
of these amino acid changes was constructed. A comparison of its
processing with that of the Gly18 pCal is shown in Fig.
4. This pCal derivative was processed so
rapidly that a [35S]methionine pulse of 15 s rather
than 1 min was required for its analysis. The majority of Ser13Gly18
pCal synthesized during the pulse was matured within the following
30 s, with no accumulation of the pCalm intermediate,
and the signal peptide was hydrolyzed with a half-life of less than 2 min. As found in the longer pulse-chase experiments, the Gly18 pCal,
the more rapidly processed of the two single mutation derivatives, was
essentially completely processed within 5 min of the end of the pulse
and released a stable signal peptide. Little processing of wild-type
pCal was observed in these short pulse-chase experiments (data not
shown).

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 4.
Short pulse-chase analysis of Gly18 and Ser13-Gly18
signal peptide processing. W3110 cells containing pKANG18 and
pKANS13G18 were induced with mitomycin C and pulse-labeled for 15 s with [35S]methionine. Samples and immunoprecipitates of
samples taken after the times indicated in seconds (") or minutes after
the beginning of the pulse were electrophoresed, and autoradiographs
were prepared. Symbols are as defined in the legend to Fig. 3.
|
|
Function of the mutant Cal proteins in colicin A release and
quasilysis.
In order to assess the biological activities of Cal
proteins which were much more rapidly lipid modified and processed than wild-type Cal or were synthesized with unstable signal peptides, we
examined colicin A release and quasilysis in cells induced for these
altered Cal proteins. In preliminary experiments in which the various
mutants were grown in rich medium in preparation for induction with
mitomycin C, we observed that the cells containing the Ser13 mutation
and especially those containing the Ser13Gly18 mutations grew more
slowly than did the wild type or the Gly18 mutant. Inspection of the
sequence of the mutant cal genes indicated that the creation
of the Ser13 missense mutation had altered the
10 region of the
colicin A immunity gene cai (which is adjacent to and
transcribed in the opposite orientation from cal
[21]) from CATGAT to CATGGA and
was thus likely interfering with expression of the immunity protein.
The Gly18 mutation also involves the substitution of a base in the
cai promoter region, from
29G to C, and this may have
further decreased the efficiency of the promoter, leading to the
greater negative effect on the double mutant. Evidence in support of
this interpretation was obtained when lawns of the wild-type and mutant
strains were plated and spotted with various dilutions of a colicin A
preparation, which demonstrated that the strains containing the Ser13
and the Ser13Gly18 mutations were much more sensitive to the colicin
than was the wild type (data not shown). In order to circumvent the
killing of the strains containing these mutations during the colicin
secretion assays, we introduced the previously isolated BD2 deletion
into the caa gene of each of the Cal mutant plasmids. The
BD2 deletion removes amino acids 15 to 30 of colicin A and inactivates
it, but has no effect on its secretion (1, 2). W3110 cells
containing pBD2 plasmid derivatives with either wild-type
cal or the cal signal sequence mutations grew
normally, and when induced with mitomycin C, all underwent quasilysis
in a manner typical of cultures induced for colicin A synthesis, except
that each of the mutants began quasilysis slightly earlier than the
wild type (Fig. 5). SDS-PAGE analysis of
the cells and supernatants obtained by centrifugation of the cultures
at various times after induction demonstrated that the wild type and
each of the mutants also produced and released the BD2 derivative of
colicin A with equal efficiency (data not shown). Finally, plate
viability assays showed that induction of the mutant and wild-type
cal genes was equally lethal, with 3-h induced cultures
typically containing approximately 2 orders of magnitude fewer viable
cells/ml than the uninduced cultures.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 5.
Quasilysis of cells induced for wild-type and mutant Cal
synthesis. Cultures were grown in Luria-Bertani medium and induced with
mitomycin C at the point indicated by the arrow (open symbols) or not
induced (closed symbols). and , W3110(pBD2); and ,
W3110(pBDS13); and , W3110(pBDG18); and ,
W3110(pBDS13G18). OD, optical density.
|
|
 |
DISCUSSION |
The effects of the Cal mutations created here on the processing
and degradation of the Cal signal peptide suggest that signal peptidase
II and the signal peptide peptidase enzymes have distinct sequence
specificities. The strong preference for Gly at the
1 position for
processing is surprising, since previous studies with the major
lipoprotein have suggested that for this protein Gly and Ala are
interchangeable at this position (17). It is possible that a
general preference for Gly exists but is masked in the major
lipoprotein by a higher level of optimization in the rest of the
cleavage region, which may include the early portion of the mature
protein. In the studies in which this region of the major lipoprotein
signal sequence was examined by in vitro mutagenesis, the Gly
Ala
mutation in the
1 position had a pronounced negative effect on the
rate of processing only when combined with mutations in the +3 and +4
positions (16).
The effect on processing observed with the Ser13 mutation, either alone
or in combination with the Gly18 mutation, indicates that the
processing enzymes also have a strong preference for a Cal signal
peptide which contains Ser rather than Ile at this position, and when
the Ser13 and Gly18 mutations were combined, the resulting pCal
derivative was completely processed within seconds of its synthesis, as
is observed for the precursors of most other secretory proteins. The
Cal signal sequence is positively charged and contains a strongly
hydrophobic central core, and thus, aside from the absence of a
moderately polar residue at the end of the hydrophobic core and the
presence of an Ala rather than a Gly in the
1 position, it strongly
resembles that of the major lipoprotein in structure. It is therefore
likely that the Ile13 and Ala18 residues of this peptide are the
primary determinants of its poor quality as a substrate for the
processing enzymes.
The striking change in the rate of degradation of the signal peptide
when Ser replaced Ile at position 13 indicates that this region of the
signal sequence is also critically important for the initial hydrolytic
attack by the signal peptide peptidase. It is not yet clear whether it
is the presence of the Ile residue itself or the conformation that it
induces which is responsible for the stability of the wild-type signal
peptide. Since the relative stability of the peptide changed in
different ways can be monitored in these cells, it should be possible
to specifically address these alternatives via the introduction of
other mutations. The sequence specificities of two putative signal
peptide peptidases, protease IV (25) and oligopeptidase A
(36), suggest that neither would degrade the mutant Cal
signal peptide more efficiently than the wild type. Although these
enzymes have been shown to degrade signal peptides in vitro, the
existence of mutants unable to produce them indicates that they are not
necessary for signal peptide degradation in vivo, suggesting that
multiple proteases may be involved in the process (25, 30).
The ability to alter the slow processing and signal sequence stability
of the Cal protein has allowed us to examine the requirements for these
features of Cal metabolism for its biological functions. The colicin
secretion assays indicated that a more rapidly processed Cal, with or
without a stable signal peptide, is at least as efficient as the
wild-type protein in causing the release of the accumulated colicin and
other proteins from the producing cells. In addition, all of these
mutant Cal proteins were equally effective at causing quasilysis of the
culture, and as for the wild type, this was accompanied by a
precipitous drop in cell viability. These results indicate that neither
the slow processing nor the stability of the signal peptide is a
requirement for these functions in vivo. In studies of the cloacin DF13
lysis protein, it was found that replacement of the entire signal
sequence with the rapidly processed and degraded signal sequence of
Braun's lipoprotein resulted in a lysis protein that was much less
efficient in cloacin release than the wild type, although quasilysis
and lethality were less affected. This suggested that the stable signal
peptide is involved in the process of cloacin release, perhaps through
the formation of a complex between the lysis protein and the signal
peptide (23). It is also clear from the data of a number of
studies that the overproduction of stable signal peptides can be lethal to E. coli and in some cases can also cause lysis of the
cell (20, 33, 35). These findings do not, however, directly
address the role of the stable signal peptides in the release of
colicins that occurs in vivo when they are produced as a consequence of the processing of colicin lysis proteins. Our findings do not indicate
whether the Cal signal peptide would be lethal to cells if it was
produced in isolation, but they do demonstrate that mature,
lipid-modified Cal, in the absence of either a stable signal peptide or
processing intermediates, is fully capable of performing the biological
function of lysis proteins
colicin release accompanied by quasilysis
and cell death. This in turn indicates that the only function that the
lysis protein signal peptide is required to perform in colicinogenesis
is that for which it is named
to act as a signal which directs the
lysis protein to the envelope.
 |
ACKNOWLEDGMENTS |
We thank M. Inukai for the gift of globomycin. The technical
assistance of R. Jahagirdar is gratefully acknowledged.
This research was funded by the Medical Research Council of Canada.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biology, University of Regina, Regina, Saskatchewan, Canada S4S 0A2. Phone: (306) 585-5223. Fax: (306) 585-4894. E-mail:
peter.howard{at}uregina.ca.
 |
REFERENCES |
| 1.
|
Baty, D.,
M. Frenette,
R. Lloubès,
V. Geli,
S. P. Howard,
F. Pattus, and C. Lazdunski.
1988.
Functional domains of colicin A.
Mol. Microbiol.
2:807-811[Medline].
|
| 2.
|
Baty, D.,
R. Lloubes,
V. Geli,
C. Lazdunski, and S. P. Howard.
1987.
Extracellular release of colicin A is non-specific.
EMBO J.
6:2463-2468[Medline].
|
| 3.
|
Cavard, D.,
D. Baty,
S. P. Howard,
H. M. Verheji, and C. Lazdunski.
1987.
Lipoprotein nature of the colicin A lysis protein: effect of amino acid substitutions at the site of modification and processing.
J. Bacteriol.
169:2187-2194[Abstract/Free Full Text].
|
| 4.
|
Cavard, D.,
S. P. Howard,
R. Lloubes, and C. Lazdunski.
1989.
High-level expression of the colicin A lysis protein.
Mol. Gen. Genet.
217:511-519[Medline].
|
| 5.
|
Cavard, D.,
C. Lazdunski, and S. P. Howard.
1989.
The acylated precursor form of the colicin A lysis protein is a natural substrate of the DegP protease.
J. Bacteriol.
171:6316-6322[Abstract/Free Full Text].
|
| 6.
|
Cavard, D.,
R. Lloubes,
J. Morlon,
M. Chartier, and C. Lazdunski.
1985.
Lysis protein encoded by plasmid ColA-CA31. Gene sequence and export.
Mol. Gen. Genet.
199:95-100[Medline].
|
| 7.
|
Chakarabartty, A.,
J. A. Schellman, and R. L. Baldwin.
1991.
Large differences in the helix propensities of alanine and glycine.
Nature
351:586-588[Medline].
|
| 8.
|
de Graaf, F. K., and B. Oudega.
1986.
Production and release of cloacin DF13 and related colicins.
Curr. Top. Microbiol. Immunol.
125:183-205[Medline].
|
| 9.
|
Dev, I. K.,
R. J. Harvey, and P. H. Ray.
1985.
Inhibition of prolipoprotein signal peptidase by globomycin.
J. Biol. Chem.
260:5891-5894[Abstract/Free Full Text].
|
| 10.
|
Gennity, J.,
J. Goldstein, and M. Inouye.
1990.
Signal peptide mutants of Escherichia coli.
J. Bioenerg. Biomembr.
22:233-269[Medline].
|
| 11.
|
Hayashi, S., and H. C. Wu.
1990.
Lipoproteins in bacteria.
J. Bioenerg. Biomembr.
22:451-471[Medline].
|
| 12.
|
Howard, S. P.,
D. Cavard, and C. Lazdunski.
1989.
Amino acid sequence and length requirements for the assembly and function of the colicin A lysis protein.
J. Bacteriol.
171:410-418[Abstract/Free Full Text].
|
| 13.
|
Howard, S. P.,
D. Cavard, and C. Lazdunski.
1991.
Phospholipase-A-independent damage caused by the colicin A lysis protein during its assembly into the inner and outer membranes of Escherichia coli.
J. Gen. Microbiol.
137:81-89[Abstract/Free Full Text].
|
| 14.
|
Howard, S. P., and L. Lindsay.
1992.
Structure/function relationships in the signal sequence of the colicin A lysis protein, p. 317-329.
In
R. James, C. Lazdunski, and F. Pattus (ed.), Bacteriocins, microcins and lantibiotics. Springer-Verlag, Berlin, Germany.
|
| 15.
|
Ichihara, S.,
N. Beppu, and S. Mizushima.
1984.
Protease IV, a cytoplasmic membrane protein of Escherichia coli, has signal peptide peptidase activity.
J. Biol. Chem.
259:9853-9857[Abstract/Free Full Text].
|
| 16.
|
Inouye, S.,
G. Duffaud, and M. Inouye.
1986.
Structural requirement at the cleavage site for efficient processing of the lipoprotein secretory precursor of Escherichia coli.
J. Biol. Chem.
261:10970-10975[Abstract/Free Full Text].
|
| 17.
|
Inouye, S.,
C. S. Hsu,
K. Itakura, and M. Inouye.
1983.
Requirement for signal peptide cleavage of Escherichia coli prolipoprotein.
Science
221:59-61[Abstract/Free Full Text].
|
| 18.
|
Inukai, M.,
M. Takeuchi,
K. Shimizu, and M. Arai.
1978.
Mechanism of action of globomycin.
J. Antibiot.
31:1203-1205[Medline].
|
| 19.
|
Ito, K.,
P. J. Bassford, Jr., and J. Beckwith.
1981.
Protein localization in E. coli: is there a common step in the secretion of periplasmic and outer membrane proteins?
Cell
24:707-717[Medline].
|
| 20.
|
Kanoh, S.,
H. Masaki,
S. Yajima,
T. Ohta, and T. Uozumi.
1991.
Signal peptide of the colicin E2 lysis protein causes host cell death.
Agric. Biol. Chem.
55:1607-1614[Medline].
|
| 21.
|
Lloubes, R.,
D. Baty, and C. Lazdunski.
1986.
The promoters of the genes for colicin production, release and immunity in the ColA plasmid: effects of convergent transcription and LexA protein.
Nucleic Acids Res.
14:2621-2636[Abstract/Free Full Text].
|
| 22.
|
Luirink, J.,
D. M. Clark,
J. Ras,
E. J. Verschoor,
F. Stegehuis,
F. K. de Graaf, and B. Oudega.
1989.
pCloDF13-encoded bacteriocin release proteins with shortened carboxyl-terminal segments are lipid modified and processed and function in release of cloacin DF13 and apparent host cell lysis.
J. Bacteriol.
171:2673-2679[Abstract/Free Full Text].
|
| 23.
|
Luirink, J.,
B. Duim,
J. W. L. De Gier, and B. Oudega.
1991.
Functioning of the stable signal peptide of the pCloDF13-encoded bacteriocin release protein.
Mol. Microbiol.
5:393-399[Medline].
|
| 24.
|
Miller, J. H.
1972.
In
Experiments in molecular genetics.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 25.
|
Novak, P., and I. K. Dev.
1988.
Degradation of a signal peptide by protease IV and oligopeptidase A.
J. Bacteriol.
170:5067-5075[Abstract/Free Full Text].
|
| 26.
|
Novak, P.,
P. H. Ray, and I. K. Dev.
1986.
Localization and purification of two enzymes from Escherichia coli capable of hydrolyzing a signal peptide.
J. Biol. Chem.
261:420-427[Abstract/Free Full Text].
|
| 27.
|
Pollitt, S.,
S. Inouye, and M. Inouye.
1986.
Effect of amino acid substitutions at the signal peptide cleavage site of the Escherichia coli major outer membrane lipoprotein.
J. Biol. Chem.
261:1835-1837[Abstract/Free Full Text].
|
| 28.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 29.
|
Schagger, H., and F. von Jagow.
1987.
A tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.
Anal. Biochem.
166:368-379[Medline].
|
| 30.
|
Suzuki, T.,
A. Itoh,
S. Ichihara, and S. Mizushima.
1987.
Characterization of the sppA gene coding for protease IV, a signal peptide peptidase of Escherichia coli.
J. Bacteriol.
169:2523-2528[Abstract/Free Full Text].
|
| 31.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 32.
|
Vallette, F.,
E. Mege,
A. Reiss, and M. Adesnik.
1989.
Construction of mutant and chimeric genes using the polymerase chain reaction.
Nucleic Acids Res.
17:723-733[Abstract/Free Full Text].
|
| 33.
|
Van Der Wal, F. J.,
B. Oudega,
M. M. Kater,
H. J. C. M. Ten,
G. F. K. De, and J. Luirink.
1992.
The stable BRP signal peptide causes lethality but is unable to provoke the translocation of cloacin DF13 across the cytoplasmic membrane of Escherichia coli.
Mol. Microbiol.
6:2309-2318[Medline].
|
| 34.
|
Van Der Wal, F. J.,
C. M. Ten Hagen,
B. Oudega, and J. Luirink.
1995.
The stable bacteriocin release protein signal peptide, expressed as a separate entity, functions in the release of cloacin DF13.
FEMS Microbiol. Lett.
131:173-177[Medline].
|
| 35.
|
Van Der Wal, F. J.,
Q. A. Valent,
C. M. Ten Hagen Jongman,
F. K. de Graaf,
B. Oudega, and J. Luirink.
1994.
Stability and function of the signal peptide of the pCloDF13-derived bacteriocin release protein.
Microbiology
140:369-378[Abstract/Free Full Text].
|
| 36.
|
Vimr, E. R.,
L. Green, and C. G. Miller.
1983.
Oligopeptidase-deficient mutants of Salmonella typhimurium.
J. Bacteriol.
153:1259-1265[Abstract/Free Full Text].
|
| 37.
|
Vlasuk, G. P.,
S. Inouye, and M. Inouye.
1984.
Effects of replacing serine and threonine residues within the signal peptide on the secretion of the major outer membrane lipoprotein of Escherichia coli.
J. Biol. Chem.
259:6195-6200[Abstract/Free Full Text].
|
| 38.
|
Von Heijne, G.
1990.
The signal peptide.
J. Membr. Biol.
115:195-201[Medline].
|
J Bacteriol, June 1998, p. 3026-3030, Vol. 180, No. 12
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cascales, E., Buchanan, S. K., Duche, D., Kleanthous, C., Lloubes, R., Postle, K., Riley, M., Slatin, S., Cavard, D.
(2007). Colicin Biology. Microbiol. Mol. Biol. Rev.
71: 158-229
[Abstract]
[Full Text]
-
Dekker, N., Tommassen, J., Verheij, H. M.
(1999). Bacteriocin Release Protein Triggers Dimerization of Outer Membrane Phospholipase A In Vivo. J. Bacteriol.
181: 3281-3283
[Abstract]
[Full Text]